Paul Tudor Jones Johnson & Johnson Call Options Transaction History

Tudor Investment Corp Et Al

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $2.91 Million - $3.35 Million	-20,000 Reduced 44.44%	25,000 $4.05 Million
Q2 2024 Aug 14, 2024	SELL	$144.38 - $157.78 $8.06 Million - $8.8 Million	-55,800 Reduced 55.36%	45,000 $6.58 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $2.7 Million - $2.83 Million	-17,400 Reduced 14.72%	100,800 $15.9 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $11.3 Million - $12.4 Million	77,800 Added 192.57%	118,200 $18.5 Million
Q3 2023 Nov 15, 2023	BUY	$155.75 - $174.48 $4.63 Million - $5.18 Million	29,700 Added 277.57%	40,400 $6.29 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $848,925 - $913,605	-5,500 Reduced 33.95%	10,700 $1.77 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $1.89 Million - $2.25 Million	12,500 Added 337.84%	16,200 $2.51 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $2.9 Million - $3.25 Million	-18,100 Reduced 83.03%	3,700 $655,000
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $1.71 Million - $1.9 Million	10,600 Added 94.64%	21,800 $3.56 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $824,131 - $911,449	4,900 Added 77.78%	11,200 $1.99 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $126,511 - $143,672	-800 Reduced 11.27%	6,300 $1.12 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $31.3 Million - $34.8 Million	-200,900 Reduced 96.59%	7,100 $1.22 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $33.6 Million - $37.3 Million	208,000 New	208,000 $33.6 Million

4,290

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $384B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.